Page 36 - CIRN Annual Report 2017
P. 36

through 2013/14 season: A pooled analysis from the Serious Outcomes Surveillance
                        Invasive Bacterial Diseases Network (TIBDN). Influenza vaccine effectiveness in the
                                                   Network (TIBDN) The importance of frailty in the assessment of trivalent inactivated
                                      Boivin, W Bowie, A Chit, M ElSherif, K Green, S Halperin, B Ibarguchi, J Johnstone,
                               (SOS) Network of the Canadian Immunization Research Network (CIRN). Canadian
                                    MK Andrew, V Shinde, L Ye, T Hatchette, F Haguinet, G Dos Santos, A Ambrose, G
                MacKinnon-Cameron, A McCarthy, JE McElhaney, A McGeer, A Poirier, J Powis, D
                          prevention of influenza-related hospitalization in Canadian adults over the 2011/12
                      Network of the Canadian Immunization Research Network (CIRN) and the Toronto
             J Johnstone, K Katz, JM Langley, J LeBlanc, P Lagace-Wiens, B Light, M Loeb, D
                                                 Influenza Research Network (PCIRN) and the Toronto Invasive Bacterial Diseases
                  Richardson, M Semret, V Shinde, S Smith, D Smyth, G Stiver, G Taylor, S Trottier,
                                               of the Public Health Agency of Canada/Canadian Institutes of Health Research
                                            Webster, SA McNeil; on behalf of the Serious Outcomes Surveillance Network
                    L Valiquette, D Webster, L Ye; on behalf of the Serious Outcomes Surveillance
                                          McGeer, J Powis, D Richardson, M Semret, G Stiver, S Trottier, L Valiquette, D
                                        K Katz, J Langley, J Leblanc, M Loeb, D MacKinnon-Cameron, A McCarthy, A
                                 Immunization Conference, Dec 6-8, 2016. Ottawa, ON.

                                                       influenza vaccine effectiveness against influenza-related hospitalization in elderly  KA Top, J Zafack, G De Serres, SA Halperin; for the PCIRN Investigators. Canadian  paediatricians’ approaches to managing patients with adverse events following  immunization: The role of the Special Immunization Clinic network. Paediatr Child  KA Top, G De Serres, M-C Gariepy, SA Halperin, F Boucher, A Carignan, F Diaz- Mitoma, S Dobson, A McConn
                                                       people. Revisions requested, JID, 2017. SPECIAL IMMUNIZATION CLINICS NETWORK








                                                                      Health. 2014;19(6):310–314.   Apr 16–18; Charlottetown, PE.







             Bacterial Diseases Network (TIBDN). Vaccine effectiveness (VE) of non-adjuvanted
                                           uenza vaccine                rmed










                        Immunization Conference, Dec 6-8, 2016. Ottawa, ON.





                                                                              Conference, Dec 6-8, 2016. Ottawa, ON.  Conference, Dec 6-8, 2016. Ottawa, ON.
                  and adjuvanted trivalent inactivated influenza vaccines (TIV) in the prevention of  influenza-related hospitalization in Canadian seniors over the 2011/12 through  2013/14 season: A pooled analysis from the Serious Outcomes Surveillance (SOS)  Network of the Canadian Immunization Research Network (CIRN). Canadian  MK Andrew, S MacDonald, L Ye, A Ambrose, G Boivin, F Diaz-Mitoma, W Bowie,  A Chit, G Dos Santos, M ElSherif, K Green, T Hatchette, F Haguinet, S Halperin,













                                                                                                                      34
   31   32   33   34   35   36   37   38   39   40